Indunil Karunarathna: Kawasaki Disease at the Intersection of Immunology, Cardiology, and Vascular Biology
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Kawasaki disease is a unique pediatric inflammatory disorder that occupies a critical intersection between immunology, cardiology, and vascular biology.
Although classically described as an acute, self-limited febrile illness of childhood, it is now understood to be a complex immune-mediated vasculitis with the potential for lifelong cardiovascular consequences.
The disease process is driven by dysregulated innate and adaptive immune responses that target the vascular endothelium, particularly within the coronary arteries, leading to aneurysm formation, thrombosis, and long-term vascular remodeling.
Early diagnosis and timely immunomodulatory therapy, especially intravenous immunoglobulin, dramatically reduce morbidity and mortality, transforming outcomes from historically fatal to largely survivable.
However, survival does not equate to cure.
Even in patients whose coronary aneurysms regress, persistent endothelial dysfunction and vascular scarring confer long-term cardiovascular risk.
Kawasaki disease should therefore not be conceptualized as a transient pediatric illness, but rather as a lifelong cardiovascular condition originating in childhood, requiring structured acute management, long-term surveillance, and transitional care into adulthood.”
Title: Kawasaki Disease: An Immune-Mediated Vasculopathy with Lifelong Cardiovascular Consequences
Authors: Indunil Karunarathna, Prasan Gunasena, Kap Gunawardana, Sam Rajapaksha, Palith Aluthge, Asok Jayawardana, Cam Fernando, USG Vidanagama, UPN Ekanayake, TMB Hapuarachchi, Sach Senanayaka, Ban Rathnayak, AN Thilak Warnakulasooriya, Palinda Athulgama, Mud Abeyek, San Dius, Ram Ranwala, Sanj Godage, Suni Senadeera, Jaga Wijepala, Neha Perera, Sena Gunathilake, Kap De Alvis, PNG Rodrigo
Read the Full Article on Uva Clinical Anaesthesia and Intensive Care
Other posts featuring Indunil Karunarathna on Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk